Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Kinin B1 receptor homo-oligomerization is required for receptor trafficking to the cell surface.

Sandén, Caroline LU and Leeb-Lundberg, Fredrik LU (2013) In International Immunopharmacology 15(1). p.121-128
Abstract
The kinin B1 receptor (B1R) is a G protein-coupled receptor with pro-inflammatory activity that is latent in healthy tissues but induced by tissue insult. Here, we investigated if B1R homo-oligomerization is a possible mechanism regulating the presentation of this receptor at the level of maturation and trafficking to the cell surface. To this end, we used HEK293 cells stably expressing N-terminal FLAG and HA epitope-tagged wild-type human B1R and an N-terminal receptor fragment, B1stop135, which terminates at the C-terminal end of the third transmembrane domain and has previously been shown to oligomerize with B1R. Receptors were monitored by immunoblotting and immunoprecipitation, receptor function by agonist binding and agonist-promoted... (More)
The kinin B1 receptor (B1R) is a G protein-coupled receptor with pro-inflammatory activity that is latent in healthy tissues but induced by tissue insult. Here, we investigated if B1R homo-oligomerization is a possible mechanism regulating the presentation of this receptor at the level of maturation and trafficking to the cell surface. To this end, we used HEK293 cells stably expressing N-terminal FLAG and HA epitope-tagged wild-type human B1R and an N-terminal receptor fragment, B1stop135, which terminates at the C-terminal end of the third transmembrane domain and has previously been shown to oligomerize with B1R. Receptors were monitored by immunoblotting and immunoprecipitation, receptor function by agonist binding and agonist-promoted phosphoinositide hydrolysis, and receptor trafficking by confocal immunofluorescence microscopy. When expressed alone, B1R is core N-glycosylated and forms oligomers localized intracellularly and on the cell surface. B1stop135 also exists as core N-glycosylated oligomers but is localized exclusively intracellularly. When co-expressed, B1stop135 prevents specifically B1R homo-oligomerization by forming nonfunctional B1R-B1stop135 hetero-oligomers, retains B1R intracellularly at least in part in the endoplasmatic reticulum (ER), increases calnexin binding to the receptor, and increases receptor degradation. We conclude that B1R homo-oligomerization is necessary for B1R maturation and trafficking to the cell surface. Modulating this mechanism may be a novel therapeutic avenue in inflammatory disease. (Less)
Please use this url to cite or link to this publication:
author
and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
International Immunopharmacology
volume
15
issue
1
pages
121 - 128
publisher
Elsevier
external identifiers
  • wos:000315075400017
  • pmid:23201435
  • scopus:84872350044
ISSN
1878-1705
DOI
10.1016/j.intimp.2012.11.012
language
English
LU publication?
yes
id
ed7e9cb0-1443-4436-9597-54b2590edf9f (old id 3347785)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23201435?dopt=Abstract
date added to LUP
2016-04-01 11:11:27
date last changed
2022-01-26 06:07:16
@article{ed7e9cb0-1443-4436-9597-54b2590edf9f,
  abstract     = {{The kinin B1 receptor (B1R) is a G protein-coupled receptor with pro-inflammatory activity that is latent in healthy tissues but induced by tissue insult. Here, we investigated if B1R homo-oligomerization is a possible mechanism regulating the presentation of this receptor at the level of maturation and trafficking to the cell surface. To this end, we used HEK293 cells stably expressing N-terminal FLAG and HA epitope-tagged wild-type human B1R and an N-terminal receptor fragment, B1stop135, which terminates at the C-terminal end of the third transmembrane domain and has previously been shown to oligomerize with B1R. Receptors were monitored by immunoblotting and immunoprecipitation, receptor function by agonist binding and agonist-promoted phosphoinositide hydrolysis, and receptor trafficking by confocal immunofluorescence microscopy. When expressed alone, B1R is core N-glycosylated and forms oligomers localized intracellularly and on the cell surface. B1stop135 also exists as core N-glycosylated oligomers but is localized exclusively intracellularly. When co-expressed, B1stop135 prevents specifically B1R homo-oligomerization by forming nonfunctional B1R-B1stop135 hetero-oligomers, retains B1R intracellularly at least in part in the endoplasmatic reticulum (ER), increases calnexin binding to the receptor, and increases receptor degradation. We conclude that B1R homo-oligomerization is necessary for B1R maturation and trafficking to the cell surface. Modulating this mechanism may be a novel therapeutic avenue in inflammatory disease.}},
  author       = {{Sandén, Caroline and Leeb-Lundberg, Fredrik}},
  issn         = {{1878-1705}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{121--128}},
  publisher    = {{Elsevier}},
  series       = {{International Immunopharmacology}},
  title        = {{Kinin B1 receptor homo-oligomerization is required for receptor trafficking to the cell surface.}},
  url          = {{https://lup.lub.lu.se/search/files/2454361/3632121.pdf}},
  doi          = {{10.1016/j.intimp.2012.11.012}},
  volume       = {{15}},
  year         = {{2013}},
}